Literature DB >> 23094886

Elimination of fatal arrhythmias through ablation of triggering premature ventricular contraction in type 3 long QT syndrome.

Zhongwei Cheng1, Peng Gao, Kang'an Cheng, Taibo Chen, Hua Deng, Bingxi Chang, Quan Fang.   

Abstract

Congenital long QT syndrome (LQTS) is the most common inherited arrhythmia, fatal arrhythmias are the main causes of sudden death, and often induced by the premature ventricular contractions (PVCs). Ablation of the triggering PVCs may eliminate the fatal arrhythmias and prevent the sudden death in patients with LQTS. We report a 19-year-old boy diagnosed with type 3 LQTS, frequent fatal arrhythmias induced by PVCs with the identical QRS morphology. Successful ablation of the triggering PVCs was done and a single-chamber implantable cardioverter defibrillator (ICD) was implanted. There was no fatal arrhythmia events recorded by ICD during 29-month follow-up. Catheter ablation was the effective method to eliminate the fatal arrhythmias through ablation of the triggering PVCs in the present LQT3 patient.
© 2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23094886      PMCID: PMC6932023          DOI: 10.1111/j.1542-474X.2012.00515.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  10 in total

1.  The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel.

Authors:  Q Wang; S Chen; Q Chen; X Wan; J Shen; G A Hoeltge; A A Timur; M T Keating; G E Kirsch
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

2.  R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese.

Authors:  H W Hwang; J J Chen; Y J Lin; R C Shieh; M T Lee; S I Hung; J Y Wu; Y T Chen; D M Niu; B T Hwang
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

3.  SCN5A R1193Q polymorphism associated with progressive cardiac conduction defects and long QT syndrome in a Chinese family.

Authors:  A Sun; L Xu; S Wang; K Wang; W Huang; Y Wang; Y Zou; J Ge
Journal:  J Med Genet       Date:  2008-02       Impact factor: 6.318

4.  Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes.

Authors:  H Huang; Juan Zhao; Fatima-Zahra Barrane; Jean Champagne; Mohamed Chahine
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

5.  Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract.

Authors:  Takashi Noda; Wataru Shimizu; Atsushi Taguchi; Takeshi Aiba; Kazuhiro Satomi; Kazuhiro Suyama; Takashi Kurita; Naohiko Aihara; Shiro Kamakura
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

6.  A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect.

Authors:  Dau-Ming Niu; Betau Hwang; Han-Wei Hwang; Nana H Wang; Jer-Yuarn Wu; Pi-Chang Lee; Jen-Chung Chien; Ru-Chi Shieh; Yuan-Tsong Chen
Journal:  J Med Genet       Date:  2006-05-17       Impact factor: 6.318

7.  Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation.

Authors:  Michel Haïssaguerre; Dipen C Shah; Pierre Jaïs; Morio Shoda; Josef Kautzner; Thomas Arentz; Dietrich Kalushe; Alan Kadish; Mike Griffith; Fiorenzo Gaïta; Teiichi Yamane; Stephane Garrigue; Meleze Hocini; Jacques Clémenty
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

8.  Prophylactic catheter ablation for the prevention of defibrillator therapy.

Authors:  Vivek Y Reddy; Matthew R Reynolds; Petr Neuzil; Allison W Richardson; Milos Taborsky; Krit Jongnarangsin; Stepan Kralovec; Lucie Sediva; Jeremy N Ruskin; Mark E Josephson
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

9.  Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

Authors:  Corrado Carbucicchio; Matteo Santamaria; Nicola Trevisi; Giuseppe Maccabelli; Francesco Giraldi; Gaetano Fassini; Stefania Riva; Massimo Moltrasio; Manuela Cireddu; Fabrizio Veglia; Paolo Della Bella
Journal:  Circulation       Date:  2008-01-02       Impact factor: 29.690

10.  Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.

Authors:  Michel Haïssaguerre; Fabrice Extramiana; Mélèze Hocini; Bruno Cauchemez; Pierre Jaïs; Jose Angel Cabrera; Jerónimo Farré; Gerónimo Farre; Antoine Leenhardt; Prashanthan Sanders; Christophe Scavée; Li-Fern Hsu; Rukshen Weerasooriya; Dipen C Shah; Robert Frank; Philippe Maury; Marc Delay; Stéphane Garrigue; Jacques Clémenty
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

  10 in total
  2 in total

1.  Catheter Ablation of Polymorphic Ventricular Tachycardia and Ventricular Fibrillation.

Authors:  Josef Kautzner; Petr Peichl
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

Review 2.  Catheter ablation for ventricular tachyarrhythmia in patients with channelopathies.

Authors:  Nobuyuki Murakoshi; Kazutaka Aonuma
Journal:  J Arrhythm       Date:  2016-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.